Clinical Trials Directory

Trials / Completed

CompletedNCT00598416

Psychoeducation for Hepatitis and Alcohol Behaviors

Psychoeducation for HCV and Alcohol Behaviors

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
556 (actual)
Sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA) · NIH
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The proposed project will apply a unique, effective family-responsive psychoeducation program, PsychoEducation Responsive to Families (PERF), for Hepatitis C Virus (HCV) treatment. The goal is to demonstrate that the intervention will enlarge the eligibility of some patients for HCV treatment and help sustain others through it.

Detailed description

This study aims to evaluate the utility of a psychosocial intervention (PsychoEducation Responsive to Families; PERF), applied to help patients prepare for and sustain HCV treatment in the treatment setting. Through careful psychiatric diagnosis and multiple longitudinal assessments, this study will also shed further light on the course of comorbid alcohol use, drug use, and other psychiatric syndromes and their interrelationships. The proposed study combines an innovative psychoeducation program with traditional HCV patient care and education. The goal of this work is to improve treatment adherence, allowing individual drug regimens to achieve their optimal effectiveness and reach a wider patient population. Support and sustenance of patients from a psychosocial perspective while they are in treatment should also help deliver more patients to sustained suppression of HCV as well as help presently untreated patients and populations become candidates for this therapy-ultimately reducing the disease burden of increasing numbers of patients needing liver transplantation or facing imminent death.

Conditions

Interventions

TypeNameDescription
BEHAVIORALFamily-Responsive Psychoeducation Program (PERF)Group psychoeducation for HCV patients and their primary caregiver.

Timeline

Start date
2006-09-01
Primary completion
2013-08-01
Completion
2013-08-01
First posted
2008-01-21
Last updated
2014-11-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00598416. Inclusion in this directory is not an endorsement.